SLC2A9 and cardiovascular disorder: His research involves basic science experiments, innovative applications of imaging techniques, and the design and execution of large clinical trials.[44–46] He is the principal investigator of several significant studies, including those on urate transporters and various pharmacological treatment strategies.[47] Additionally, he has investigated the impact of gout on patients’ quality of life and its association with cardiovascular diseases.[48]